Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chuning Shi

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Redox Biology|January 23, 2022
An unexpected role for BAG3 in regulating PARP1 ubiquitination in oxidative stress-related endothelial damageNaijin Zhang, Ying Zhang, Wei Miao, et al.
JAMA Network Open|July 11, 2025
Intensive Systolic Blood Pressure Reduction and Kidney and Cardiovascular Outcomes: A Secondary Analysis of a Randomized Clinical TrialGuozhe Sun, Wei Miao, Songyue Liu, et al.
JAMA Cardiology|June 18, 2024
Multifaceted Intensive Blood Pressure Control Model in Older and Younger Individuals With Hypertension: A Randomized Clinical TrialXiaofan Guo, Nanxiang Ouyang, Guozhe Sun, et al.
BMC Medicine|June 20, 2024
Impact of baseline cardiovascular risk on the outcomes of intensive blood pressure intervention: a post hoc analysis of the China rural hypertension control projectGuozhe Sun, Chang Wang, Ning Ye, et al.
Lancet (London, England)|March 5, 2023
Effectiveness of a non-physician community health-care provider-led intensive blood pressure intervention versus usual care on cardiovascular disease (CRHCP): an open-label, blinded-endpoint, cluster-randomised trialJiang He, Nanxiang Ouyang, Xiaofan Guo, et al.
Lancet (London, England)|September 3, 2025
Benefit-harm trade-offs of intensive blood pressure control versus standard blood pressure control on cardiovascular and renal outcomes: an individual participant data analysis of randomised controlled trialsXiaofan Guo, Guozhe Sun, Yu Xu, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Redox Biology|January 23, 2022
An unexpected role for BAG3 in regulating PARP1 ubiquitination in oxidative stress-related endothelial damageNaijin Zhang, Ying Zhang, Wei Miao, et al.
JAMA Network Open|July 11, 2025
Intensive Systolic Blood Pressure Reduction and Kidney and Cardiovascular Outcomes: A Secondary Analysis of a Randomized Clinical TrialGuozhe Sun, Wei Miao, Songyue Liu, et al.
JAMA Cardiology|June 18, 2024
Multifaceted Intensive Blood Pressure Control Model in Older and Younger Individuals With Hypertension: A Randomized Clinical TrialXiaofan Guo, Nanxiang Ouyang, Guozhe Sun, et al.
BMC Medicine|June 20, 2024
Impact of baseline cardiovascular risk on the outcomes of intensive blood pressure intervention: a post hoc analysis of the China rural hypertension control projectGuozhe Sun, Chang Wang, Ning Ye, et al.
Lancet (London, England)|March 5, 2023
Effectiveness of a non-physician community health-care provider-led intensive blood pressure intervention versus usual care on cardiovascular disease (CRHCP): an open-label, blinded-endpoint, cluster-randomised trialJiang He, Nanxiang Ouyang, Xiaofan Guo, et al.
Lancet (London, England)|September 3, 2025
Benefit-harm trade-offs of intensive blood pressure control versus standard blood pressure control on cardiovascular and renal outcomes: an individual participant data analysis of randomised controlled trialsXiaofan Guo, Guozhe Sun, Yu Xu, et al.
Pageof 2